REGN
Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN
966.68 USD38.79 +4.18%
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) last traded at 966.68 USD, up 4.18% on the day. Over the past year the stock is up 48.85%. Its 52-week range is 591.52 to 974.00. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open927.22
Day range927.00 – 974.00
52-week range591.52 – 974.00
Volume916.37 K
Average volume (10 days)884.78 K
Market cap99.51 B
P/E21.34
EPS (TTM)45.30
Dividend yield0.40%
Beta (1 year)−0.0899
Revenue (TTM)16.90 B
Employees15.41 K
Performance
+19.00%1 week
+30.54%1 month
+28.25%3 months
+37.44%6 months
+24.85%Year to date
+48.85%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Regeneron Pharma Price Target Raised to $855.00/Share From $779.00 by Morgan StanleyDow Jones Newswires · 02 Nov 2026
- Morgan Stanley maintains Regeneron Pharmaceuticals at Equal-Weight, raises price target to $855 from $779TradingView · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $913.00/Share From $810.00 by RBC CapitalDow Jones Newswires · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $982.00/Share From $780.00 by Truist SecuritiesDow Jones Newswires · 02 Nov 2026
- Truist Securities maintains Regeneron Pharmaceuticals at Buy, raises price target to $982 from $780TradingView · 02 Nov 2026
- RBC Capital maintains Regeneron Pharmaceuticals at Sector Perform, raises price target to $913 from $810TradingView · 02 Nov 2026
- Regeneron Pharma Is Maintained at Buy by GuggenheimDow Jones Newswires · 02 Nov 2026
- Guggenheim maintains Regeneron Pharmaceuticals at Buy, raises price target to $1100 from $1030TradingView · 02 Nov 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.